Skip to main content

Animations

MJFF Publications

3581 - 3590 of 6466 Results
Title
Year
  • Year
  • 2021
  • 2025
  • 2021
  • 2013
  • 2023
  • 2014
  • 2024
  • 2016
  • 2017
  • 2017
  • Summary Details
    OPEN
    Title: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2025.123731
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease Impulsivity
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.03.002
    Citation Count: 13
  • Disease-modifying therapies for Parkinson's disease
    2013
    Summary Details
    OPEN
    Title: Disease-modifying therapies for Parkinson's disease
    Journal Name: The Biomedical & Life Sciences Collection
    Publisher: Henry Stewart Talks
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.69645/krxj9755
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease
    Journal Name: Journal of Biopharmaceutical Statistics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/10543406.2023.2170400
    Citation Count: 8
  • Summary Details
    OPEN
    Title: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a
    Journal Name: Journal of Neuroimmunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain
    Journal Name: Nanoscale
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d4nr03002h
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samples
    Journal Name: Journal of Chromatography A
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.chroma.2016.04.006
    Citation Count: 251
  • Summary Details
    OPEN
    Title: Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00216
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Parkinson's disease prevalence in Fabry disease: A survey study
    Journal Name: Molecular Genetics and Metabolism Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.